New Drug Finerenone Offers Hope for Millions with Chronic Kidney Disease Without Diabetes
A new drug, finerenone, previously used for diabetic kidney disease, has shown significant benefits for patients with chronic kidney disease (CKD) not caused by diabetes. Studies indicate it slows kidney decline, reduces the risk of kidney failure, and lowers cardiovascular complications, offering hope to millions worldwide.



















